Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial

Gastroenterology

Volumn 116, Issue 3, 1999, Pages 521-526

  Prantera, C ^a   Cottone, M ^a   Pallone, F ^a   Annese, V ^a   Franze, A ^a   Cerutti, R ^a   Porro, G B ^a   Rotondo, S G ^a   Andriulli, A ^a   Ardizzone, S ^a   Capurso, L ^a   Papi, C ^a   Rosselli, M ^a   Oliva, L ^a   Dimitri, R ^a   D'Albasio, G ^a   Bonanomi, A ^a   Milla, M ^a   De Franchis, R ^a   Vecchi, M ^a   Marcucci, D ^a   Mazzacca, G ^a   Castiglione, F ^a   Sturniolo, G ^a   D'Inca, R ^a   Monteleone, G ^a   Berto, E ^a   Scribano, M L ^a   Zannoni, F ^a   Saggioro, A ^a   Caroli, M ^a   Vetrano, S ^a   Verme, G ^a   Pera, A ^a   Astegiano, A ^a   more..

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EUDRAGIT; GELATIN; MESALAZINE; METHYLPREDNISOLONE;

ACNE; ACUTE PANCREATITIS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; FEMALE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TABLET;

EID: 0033047587     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70172-1     Document Type: Article

References (27)

1. BI. Korelitz The role of steroids in the management of Crohn's disease C Prantera B Korelitz Crohn's disease. 1996 Marcel Dekker New York 253 258
2. JW Singleton SB Hanauer GL Gitnick MA Peppercorn MG Robinson LD Wruble EL Krawitt the Pentasa Crohn's Disease Study Group Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial Gastroenterology 104 1993 1293 1301
3. WJ Tremaine KW Schoeder JM Harrison AR. Zinsmeister A randomized, double blind, placebo-controlled trial of oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis J Clin Gastroenterol 19 1994 278 282
4. C Prantera F Pallone G Brunetti M Cottone M Miglioli IBD the Italian Study Group Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease Gastroenterology 103 1992 363 368
5. C Cammà M Giunta M Rosselli M. Cottone Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables Gastroenterology 113 1997 1465 1473
6. SN Rasmussen K Lauritsen U Tage-Jensen OH Nielsen P Bytzer O Jacobsen K Ladefoged M Vilien V Binder J Rak-Madsen S Bondensen S Honorè Hansen EF. Hvidberg Five-aminosalicylic acid in the treatment of Crohn's disease: a 16-week double blind, placebo-controlled, multicenter study with Pentasa Scand J Gastroenterol 22 1987 877 883
7. J Scholmerich H Jenss F Hartmann H Dopper the German 5-ASA Study Group Oral 5-aminosalicylic acid versus 6-methylprednisolone in active Crohn's disease Can J Gastroenterol 4 1990 446 450
8. F Martin L Sutherland IT Beck AH Anderson CN Williams F Saibil J Barrowman S. Lemire Oral 5-ASA versus prednisone in short-term treatment of Crohn's disease: a multicenter controlled trial Can J Gastroenterol 4 1990 452 457
9. JW. Singleton Second trial of mesalamine therapy in the treatment of active Crohn's disease Gastroenterology 107 1994 632 633
10. JP Wright DP Jewell R Modigliani H Malchow for the International Organization for the study of inflammatory bowel disease IOIBD A randomized, double blind, placebo controlled trial of olsalazine for active Crohn's disease Inflammatory Bowel Dis 1 1995 241 246
11. DB Sachar HA Andrews RG Farmer F Pallone AS Pena C Prantera P. Rutgeerts Proposed classification of patient subgroups in Crohn's disease Gastroenterol Int 5 1992 141 154
12. RG Farmer G Whelan VW. Fazio Long-term follow up of patients with Crohn's disease: relationship between the clinical pattern and prognosis Gastroenterology 88 1985 1818 1825
13. PAM Van Hees JH Bakker JHM. Van Tongeren Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine Gut 21 1980 632 635
14. LR Sutherland F Martin S Greer M Robinson N Greenberger F Saibil T Martin J Sparr ED Prokipchuk L. Borgen 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis Gastroenterology 92 1987 1894 1898
15. M Campieri P Gionchetti A Belluzzi C Brignola GM Tabanelli M Miglioli L. Barbara 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol 10 1988 406 409
16. M De Vos H Verdievel R Schoonjans M Praet M Bogaert F. Barbier Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations Gut 33 1992 1338 1342
17. C Prantera ML Scribano E. Berto Treatment of active Crohn's disease with salazopyrine and derivatives of aminosalicylic acid (5-ASA) C Prantera B Korelitz Crohn's disease. 1996 Marcel Dekker New York 233 251
18. International Mesalazine Study Group Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease Aliment Pharmacol Ther 4 1990 55 64
19. A Bossi P Gionchetti M Campieri F Milesi R De Iasio L Bortoluzzi G Grandinetti G Brunetti M. Miglioli Comparative pharmacokinetic study of two multiple and single unit controlled release oral dosage forms of 5-ASA (abstr) It J Gastroenterol 23 1991 641
20. P Gionchetti M Campieri I Cappello G Mazzoni A Belluzzi G Brunetti M Miglioli L. Barbara Gastrointestinal transit and drug delivery of two multiple-unit controlled release formulations (abstr) Ital J Gastroenterol 23 1991 644
21. RW Summers DM Switz JT Sessions Jr JM Becktel WR Best F Kern Jr JW. Singleton National cooperative Crohn's disease study: results of drug treatment Gastroenterology 77 1979 847 869
22. H Malchow K Ewe JW Brandes H Goebell H Ehems H Sommer H. Jesdinsky European cooperative Crohn's disease study (EC-CDS): results of drug treatment Gastroenterology 86 1984 249 266
23. WR Best JM Bektel JW Singleton F. Kern Development of a Crohn's disease activity index: national cooperative Crohn's disease study Gastroenterology 70 1976 439 444
24. D Gillings G. Koch The application of the principle of intention-to-treat to the analysis of clinical trials Drug Inf J 25 1991 411 424
25. OO Thomsen A Cortot D Jewell JP Wright T Winter FT Veloso M Vatn T Persson E. Petterson A comparison of budesonide and mesalamine for active Crohn's disease N Engl J Med 339 1998 370 374
26. PH Layer H Goebell J Keller A Dignass U. Klotz Delivery and fate of oral mesalamine microgranules within the human small intestine Gastroenterology 108 1995 1427 1433
27. P Rutgeerts R Lofberg H Malchow C Lamers G Olaison D Jewell A Danielsson H Goebell O Thomsen H Lorenz-Meyer H Hodgson T Persson C. Seidegard A comparison of budesonide with prednisolone for active Crohn's disease N Engl J Med 331 1994 842 845